Glycophos

Product NDC: 63323-241
11-digit product format: 633230241
Labeler code: 63323
Product ID: 63323-241_aeed61b6-c0c3-416d-be37-991dd58a4950
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: SODIUM GLYCOLATE
Dosage form: INJECTION, SOLUTION
Route: INTRAVENOUS
Labeler: Fresenius Kabi USA, LLC
Marketing category: UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE
Marketing start: 2013-05-13
Marketing end: 0000-00-00
Substance: SODIUM GLYCEROPHOSPHATE ANHYDROUS
Active strength: 216 mg/mL
NDC exclude flag: No
Listing certified through: 2023-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	63323-241		I	Inactivated by FDA		2026-08-17
excluded package	package	63323-241	63323-241-20	I	Inactivated by FDA		2026-08-17

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 22 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	63323-241-20	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	63323-241-20	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	63323-241-20	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	63323-241-20	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	63323-241-20	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	63323-241-20	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	63323-241-20	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	63323-241-20	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	63323-241-20	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	63323-241-20	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	63323-241-20	`367a005e9d99…`	`383a685ebd0f…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
efd58dcf-540a-4531-8766-e713129ca6f2	Product name	1	20250307
4b7700e3-6e0e-45e5-9d22-6f754d61386e	Product name	2	20250304
726062af-1135-4707-a1d7-57256991bbf9	Product name	2	20250226
7cda52fc-125f-421c-8fea-bc1974370c49	Product name	2	20180703
0ca1d589-929b-4b33-bc5b-1d84abdafa6a	Product name	1	20150324
fc363c46-397b-4476-ac0f-70e43e8e4592	Product name	1	20150324
19c71a3d-ed9c-166b-a7e5-38c250c35631	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
63323-241-20	2024-07-30	C162847	48780-1	1e7a6dab-1af6-a2ce-e063-dadaa90aadf7	Glycophos

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
63323-241-20	Glycophos	20 mL in 1 VIAL, PLASTIC	INJECTION, SOLUTION	20		3
63323-241-20	Glycophos	10 in 1 CARTON	INJECTION, SOLUTION	10		3

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
63323-241-20	ML - Milliliter	63323-241	9e14bbc9-c26b-43b1-ba63-bdd82fd993c4	1	2013-06-04

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
SODIUM GLYCEROPHOSPHATE ANHYDROUS	ACTIVE INGREDIENT	YP1H63LJ2K	GLYCOPHOS (SODIUM GLYCOLATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]	1
PHOSPHATE ION	ACTIVE MOIETY	NK08V8K8HR	GLYCOPHOS (SODIUM GLYCOLATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]	1
HYDROCHLORIC ACID	INACTIVE INGREDIENT	QTT17582CB	GLYCOPHOS (SODIUM GLYCOLATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
63323-241	GLYCOPHOS (SODIUM GLYCOLATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]	3	Legacy NDC, 2 package rows	20221213_dcd92dc7-c6f9-4866-9edd-c95d5097c4e5.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
YP1H63LJ2K	SODIUM GLYCEROPHOSPHATE ANHYDROUS	1334-74-3	SODIUM GLYCEROPHOSPHATE ANHYDROUS
B75E535IMI	SODIUM GLYCOLATE	2836-32-0	SODIUM GLYCOLATE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
1423812	Glycophos 4.32 GM (sodium 40 mmol, phosphate 20 mmol) in 20 ML Injection	PSN	dcd92dc7-c6f9-4866-9edd-c95d5097c4e5	3
1423807	sodium glycerophosphate 4.32 GM (sodium 40 mmol, phosphate 20 mmol) in 20 ML Injection	PSN	dcd92dc7-c6f9-4866-9edd-c95d5097c4e5	3
1423812	20 ML sodium glycerophosphate 216 MG/ML Injection [Glycophos]	SBD	dcd92dc7-c6f9-4866-9edd-c95d5097c4e5	3
1423807	20 ML sodium glycerophosphate 216 MG/ML Injection	SCD	dcd92dc7-c6f9-4866-9edd-c95d5097c4e5	3
1423812	20 ML Glycophos 216 MG/ML Injection	SY	dcd92dc7-c6f9-4866-9edd-c95d5097c4e5	3
1423812	Glycophos 4.32 GM (sodium 40 mmol, phosphate 20 mmol) per 20 ML Injection	SY	dcd92dc7-c6f9-4866-9edd-c95d5097c4e5	3
1423807	sodium glycerophosphate 4.32 GM (sodium 40 mmol, phosphate 20 mmol) per 20 ML Injection	SY	dcd92dc7-c6f9-4866-9edd-c95d5097c4e5	3

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
63323-241-20	63323024120	10 VIAL, PLASTIC in 1 CARTON (63323-241-20) > 20 mL in 1 VIAL, PLASTIC	2013-05-13	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Glycophos	Fresenius Kabi USA, LLC \| Fresenius Kabi Norge AS	2022-12-07	Human Prescription Drug Label	3